In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.
Search for:
Toggle navigation
CPW's work
About
Community Pharmacies in Wales
CPW Board members
CPW Manifesto for the 2021 Welsh Parliament elections
CPW Staff
CPW LHB Forum Representatives
Consultations and Responses
Useful Links
Vision
Contact us
Address and main contact details
CPW Helpdesk
CPW Pharmacy Advice Audit 2020
CPW’s Privacy Notice
Current vacancies at CPW
Link to News
Government & Public Relations
MS and MP Visits
Political Party Conferences
Press Releases
Types of Community Pharmacy Services
Funding and statistics
2018/19 Global Sum Increase
Branded Generics
Community Pharmacy Quality Indicators
CPCF 2019-20
CPCF 2020-21 Framework Funding – distribution of funding
Dictionary of Medicines and Devices DM&D
Dispensing and Prescribing Data
Dispensing at a loss
Drug Tariff
Essential Small Pharmacies
Fees for National Enhanced Services
Welsh Government Written statement Community Pharmacy Funding 2020-21
Regulations and IT
Pharmaceutical Needs Assessment
Pharmacy IT
All Wales Pharmacy Database
Approved PMR Suppliers Wales
Choose Pharmacy IT Platform
Electronic Claiming
Electronic NHS Alert Service (ENAS)
Electronic Transmission of Claims (ETC)
Harm Reduction Database (HRD)
Helpdesk Support
IM&T Allowances
Information Governance Wales
Video Consultation Service
Regulations
Fees for Applications
General Data Protection Regulation (GDPR)
NHS (Pharmaceutical Services) (Wales) Regulations 2020
Regulations and Directions
Dispensing and supply
Accuracy of prescription pricing data
Electronic Transmission of Claims
Endorsement Guide
eReturns
Homecare Services
Items Identified as Low Value for Prescribing in Wales
Medicines Shortages
Disruptions to Supply
Lorazepam 4mg/ml
Prescription Submission for Serious Shortage Protocol Substitutions
Proposed Changes to Terms of Service for NHS Pharmacists March 2019
Serious Shortage Protocols (SSP)
Methadone Supply- Revised Arrangements
New arrangements for reimbursing specials
On-line Payment Schedule
ONPOS Guidance
Other Onpos Information
Out of Pocket Expenses
Pharmacy Reward Scheme
Post Payment Verification
Price Concessions
Primary Care Services Website
Prescription Pricing Accuracy
Provision of Compliance Aids
Shared Services Newsletters
Specials- Revised Arrangements for Dispensing Specials
Submission of Prescriptions for Pricing
Preparing Month End
Supply of Lymphoedema Garments- Revised Arrangements
Supply of medicines to Schools
Services and commissioning
Advanced Services
Choose Pharmacy
Collaborative Working
Historical Documents
Continuity
DBS Checks
Enhanced Services
Accreditation pathways for Pharmacists starting to practice in Wales
All Wales Services Data
Fees for National Enhanced Services
Supervised Administration Service
Essential Services
All Wales Temporary Closure Form
Locally Commisioned Services
CPW Template Services
Pivotell
Primary Care Clusters
Cluster Working in Wales: Handbooks
Primary Care Cluster Community Pharmacy Lead
Quality & Safety Scheme
ALL Wales Pharmacy Database (AWPD) Validation 2020-21
High Risk Medicines Survey 2020/21
Historical Documents
WG Statistic Releases on Community Pharmacy Services
The Health Landscape
About NHS Wales
Chief Medical Officer Updates
Key Strategies
Ageing Well In Wales Publications
All Wales Medicines Strategy Group (AWMSG) Guidance
Brexit
Coronavirus-Information-Updates
Community Pharmacy Communications Package – Keep Wales Safe
CPW Communications
Deliveries
Guidance on managing the pharmacy
LHB Specific Communications
Registrants Temporarily returning to the GPhC Register
Welsh Government Comms
Health in Wales Website
National Prescribing Indicators
Primary Care
Health Information Resource Service
Public Health Outcomes Framework
Public Health Strategy for Wales
Public Health Outcomes Framework
Respiratory Winter Plan
Welsh Language
Welsh Language in Primary Care FAQ
Contractors area
CPW support materials
Covid-19 Resources
June 2020 Contractor Evenings
November 2019 Contractor Evenings
November 2020 contractor Events
Independent Prescriber Enhanced Services
IP Enhanced Service
IP Services in Clusters
IP Transititional Service
CPW Board & Committee Meetings
CPW Board Meetings
Contractor news
CPW Contractor Weekly News
Fees for National Enhanced Services
Health Board Specific
Aneurin Bevan
Betsi Cadwaladr
Cardiff & Vale
Cwm Taf Morgannwg
Hywel Dda
Powys
Swansea Bay
Microsoft Office 365 NHS Email
My Account
Change password
Pharmacist/ Technicians available for work in Community pharmacy
Pre-Foundation Pharmacist Training Programme - Consultation
PSNC Check on prescription pricing accuracy
Register
Covid-19
Regulations and IT
Pharmaceutical Needs Assessment
Pharmacy IT
All Wales Pharmacy Database
Approved PMR Suppliers Wales
Choose Pharmacy IT Platform
Choose Pharmacy Implementation Plan
Choose Pharmacy Technical Specifications
National Intelligent Integrated Auditing Solutions (NIIAS)
Electronic Claiming
Electronic NHS Alert Service (ENAS)
Electronic Transmission of Claims (ETC)
ETC – Frequently Asked Questions.
ETC accredited PMR Systems
ETC Drug Tariff Requirements
Harm Reduction Database (HRD)
Helpdesk Support
IM&T Allowances
Information Governance Wales
Video Consultation Service
Regulations
Fees for Applications
General Data Protection Regulation (GDPR)
GDPR news 27th March 2018
NHS (Pharmaceutical Services) (Wales) Regulations 2020
Regulations and Directions
IM&T Allowances
6.1 The NHS Wales Informatics Service (NWIS) sets and delivers the strategic direction and corporate IM&T policy for Community Pharmacy in Wales.
6.2 There are parallel strategic developments within England and Wales in relation to the technical architectures that underpin the ‘NHS Care Records Service’ (England) and the ‘Welsh GP Record’ (Wales).
6.3 However, differences in direction and pace of these respective programmes have meant that Wales, via a national community pharmacy IM&T programme board of representative stakeholders, has determined appropriate and comparable solutions, deliverable through a pragmatic, phased approach.
Phase 1 - IT Infrastructure and Connectivity Services
6.4 In 2005/06, two allocations of £1,300 (ie a total of £2,600) were paid to all pharmacy contractors included, at that time, in a pharmaceutical list maintained by a Local Health Board in Wales. Pharmacy contractors were directed to ensure investment in systems to support the Programme’s key objectives associated with Phase 1; specifically, that funding must be targeted to ensure any investment in IT is “fit for purpose” and capable of running the latest version of the pharmacy contractors’ PMR system. The allocations applied only to pharmacy contractors included, at that time, in a pharmaceutical list maintained by a Local Health Board.
6.5 In addition, from 2007, a recurring ‘connectivity’ payment of £200pcm is made available to all contractors capable of secure/managed access to the NHS Wales network and its connectivity services, such as web eMail and HOWIS (Health of Wales Information Services).
6.6 With effect from 30 September 2010 the recurring ‘connectivity’ payment of £200pcm, include Phase 1 and Phase 2 services.
Phase 2 - Release 1 - 3
6.7 Phase 2 is being addressed as three ‘Releases’, consisting of:
Release Number
Service/System
Available Date
Maximum Deployment Timescale
1
NHS Wales-compliant Email service
(ENAS-Electronic NHS Alerts Service)
1 April 2010
30 September 2010
2
ETP - 2D-Barcoded Prescription service
30 September 2010
30 September 2011
3
Electronic Transmission of Claims service
30 April 2017
31 October 2017
6.8 With effect from 31 October 2017 all Pharmacy Contractors are required to be compliant with Phase 2 Releases 1, 2 & 3.
Pharmacy contractors will be given at least three months’ notice of their pharmacy IT system’s capability to access each respective release of Phase 2. The following website shows the current status for each of the accredited systems/suppliers for Wales and status of all the Phase 2 Releases:
http://howis.wales.nhs.uk/wmss
.
6.9 Pharmacy Contractors
are required to
inform the NHS-Shared Services Partnership-Contractor Services division whenever: 1) they commence connectivity to their individual premises, 2) have a change of system supplier, 3) have a change of accredited connectivity provider. This advice must be submitted using the ETP1 or ETP2 Claim Form, as appropriate.
6.10 A pharmacy contractor must submit the appropriately completed ETP Monthly Allowance Claim Form to
NWIS
not later than the last day of the first month that the premises can demonstrate that it is able to operate the services in Phase 2 Releases 1, 2& 3. This will instigate receipt of the monthly allowance for that month and subsequent months. The monthly recurring payment is subject to the pharmacy premises’ ongoing compliance with the specified services and their terms. If at a later date a pharmacy premises becomes unable to comply with the requirements of this part they must as soon as is practicable notify their LHB and NWIS in writing of the date from which the pharmacy ceased to be compliant. The LHB may then determine whether payment of the recurring connectivity payment should be stopped on a permanent basis or suspended for a month (or period specified by the LHB). On resumption of the service, an updated ETP Monthly Allowance Claim Form should be submitted and connectivity and compliance to the services will have to be demonstrated by the pharmacy contractor.
6.11 LHBs may monitor and audit pharmacy contractor and individual premises compliance with the services in Phase 2 Releases 1, 2 & 3. Where NHS Wales audit and monitoring identify a pharmacy premises to be non compliant with the services in Phase 2 Releases 1, 2 & 3, and where that non compliance is within the control of the pharmacy contractor, action may result in the suspension of the recurring connectivity payment and NHS connectivity.
6.12 In 2007/08, to support the implementation requirements of Phase 2, an additional one-off payment of £1,000 was paid to all pharmacy contractors included, at that time, in a pharmaceutical list maintained by a LHB in Wales. The allocation applied only to pharmacy contractors included, at that time, in a pharmaceutical list maintained by a LHB.
6.13 Failure to place an order for respective Releases of a NHS Wales compliant system or service within three months following the maximum deployment date advised could result in the £1,000 allowance also being reclaimed.
Further Information
6.14 These allowances and guidelines will be published in Part VIA of the Drug Tariff, the most recent edition of which can be found online at:
http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx
6.15 Further supplementary guidance on procedures to support the implementation of forthcoming developments will be provided, as appropriate.